1492 Capital Management LLC bought a new stake in shares of Cabot Corporation (NYSE:CBT – Free Report) in the first quarter, Holdings Channel reports. The fund bought 48,057 shares of the specialty chemicals company’s stock, valued at approximately $3,619,000. Cabot makes up approximately 1.4% of 1492 Capital Management LLC’s holdings, making the stock its 29th biggest holding.
Several other hedge funds and other institutional investors have also recently modified their holdings of CBT. Fuller & Thaler Asset Management Inc. lifted its holdings in shares of Cabot by 5.6% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock worth $155,315,000 after buying an additional 124,613 shares in the last quarter. State Street Corp grew its stake in Cabot by 1.0% during the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock valued at $134,256,000 after acquiring an additional 20,021 shares in the last quarter. American Century Companies Inc. increased its holdings in Cabot by 8.4% during the 3rd quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after acquiring an additional 140,665 shares during the period. Bank of America Corp DE increased its holdings in Cabot by 3.9% during the 3rd quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock worth $128,032,000 after acquiring an additional 63,080 shares during the period. Finally, Dimensional Fund Advisors LP lifted its stake in Cabot by 6.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,663,283 shares of the specialty chemicals company’s stock worth $110,243,000 after purchasing an additional 106,521 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors.
Analysts Set New Price Targets
Several research analysts have commented on CBT shares. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a report on Tuesday, May 26th. Truist Financial began coverage on shares of Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price target on the stock. Mizuho increased their price objective on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a research report on Thursday. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. Finally, UBS Group boosted their target price on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Two analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $85.80.
Cabot Stock Performance
NYSE CBT opened at $93.49 on Friday. Cabot Corporation has a 52-week low of $58.33 and a 52-week high of $94.53. The company has a fifty day moving average of $83.21 and a 200-day moving average of $75.73. The company has a market capitalization of $4.83 billion, a P/E ratio of 17.67, a P/E/G ratio of 12.28 and a beta of 0.82. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The business had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.30 million. During the same quarter in the prior year, the firm earned $1.90 earnings per share. The firm’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. As a group, equities research analysts predict that Cabot Corporation will post 6.34 EPS for the current fiscal year.
Cabot Increases Dividend
The company also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were issued a dividend of $0.4725 per share. The ex-dividend date of this dividend was Friday, May 29th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.0%. This is a positive change from Cabot’s previous quarterly dividend of $0.45. Cabot’s payout ratio is 35.73%.
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Recommended Stories
- Five stocks we like better than Cabot
- 3 Stocks That Could Benefit as the Robotaxi Race Heats Up
- 3 Waste Stocks Turning AI Investments into Growth
- 3 Overlooked Tech ETFs That Are Quietly Killing It This Year
- 3 ETFs Pairing Market-Beating Returns With High Dividend Yields
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
